Brief: Hemostemix Finalizes Terms Of License Agreement With Aspire Health Science
26/02/2018 13:09
Feb 26 (Reuters) - Hemostemix Inc HEM.V :
* HEMOSTEMIX INC - FINALIZED TERMS OF A LICENSE AGREEMENT
WITH
ASPIRE HEALTH SCIENCE FOR ACP-01
Source text for Eikon: ID:nGNXbl3slF
Further company coverage: HEM.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hemostemix
See all newsBrief: Hemostemix Announces Financing Update And Secured Convertible Debenture Financing Of Up To $2,000,000
Brief: Aspire Health Science Files Supplemental Motion For Expedited Hearing In Lawsuit Against Hemostemix Inc. And Suspends Patient Recruitment For Hemostemix Cli Phase 2 Clinical Trial
Brief: Aspire Health Sciences Says On Jan 28, 2020, Initiated Legal Proceeding Against Hemostemix Inc
Brief: Hemostemix Announces Private Placement
Brief: Hemostemix Announces Corporate Update